PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Immuno Laboratories, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Immuno Laboratories 2008 Practice Development Conference - The Practice Development Conference will provide physicians with the opportunity to learn from colleagues and renowned clinical and business experts, how to build their practice while achieving successful patient outcomes
Immuno Laboratories 2008 Practice Development Conference

 

NewswireToday - /newswire/ - Fort Lauderdale, FL, United States, 2008/07/17 - The Practice Development Conference will provide physicians with the opportunity to learn from colleagues and renowned clinical and business experts, how to build their practice while achieving successful patient outcomes.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Fort Lauderdale based food sensitivity testing lab, Immuno Laboratories, is hosting its second annual Practice Development Conference at the Doral Golf Resort & Spa in Miami, Florida on October 31 & November 2, 2008. The goal of this hands on conference is to provide healthcare providers with practice development strategies that build revenue and innovative therapies that will increase successful patient outcomes. Colleagues and renowned experts in clinical and business development areas will share how they transformed their practices or helped others to do so. The conference will offer 15 CME/CEU credits with instruction in such areas as nutritional medicine, Immunology, endocrinology, and diagnostic interpretation. Registration is $595 with an early bird rate of $425 until July 31. Special rates for additional staff and guests available. Registration available online.

The first day of the conference will focus on corporate wellness and practice development. The corporate wellness module discussions will include peer anecdotal presentations about the successful gaining of access to corporations, current corporate wellness studies using innovative therapies, and a panel with partnering physicians and corporations looking at what made the partnership work. The practice development module will consist of colleagues talking about innovative therapies (e.g. laser therapy, advanced ultrasound for early detection of heart disease, etc.) and marketing initiatives. This first day will also include a presentation by keynote speaker Jaynie Smith, president of “Smart Advantage” a marketing/management consultancy whose clients range from mid-sized companies to Fortune 500 companies. She consults nationally and internationally on developing your competitive advantage. She has appeared on several programs including ABC World News and NPR and has shared the stage with such speakers as Stephen Covey, Marshall Goldsmith, Jack Canfield & Jim Kouzes. She will focus on how physicians can actualize their competitive advantage.

The second day of the conference will be the CME/CEU component which will be broken up into 4 modules; nutritional medicine, immunology, endocrinology, and diagnostic interpretation. Topics will include; functional medicine, subcutaneous and sublingual immunotherapy, hyperbaric oxygen therapy, adrenal fatigue and insulin resistance, andropause, estrogen, and iodine insufficiency, pellet hormone therapy, and a panel on diagnostic interpretation. The second day will include a presentation by keynote speaker James B. LaValle, R. Ph., C.C.N., M.S, founder of the LaValle Metabolic Institute, is an educator, clinician, and industry consultant in the field of integrative healthcare.
Dr. LaValle has written 14 books, including his most recent, “Cracking the Metabolic Code”. He has had over 150 articles published, and was also the principle author of two searchable databases on natural medicine and drug induced nutrient depletion. He is a nationally known personality with over 400 radio shows and TV spots to his credit. He has trained a multitude of healthcare professionals on integrating natural therapies into clinical practice and his consulting clients have included CVS pharmacies, Rite Aid, Cardinal Health, McKesson, Long's Drug Chains, and Professional Compounding Centers of America where he has been involved in all aspects of the industry from media and product development to quality control.

The 2008 Practice Development conference has been purposely coordinated to be a boutique conference with limited exhibitors and sponsorship opportunities. This was done to allow exhibitors, sponsors, and attendees the opportunity and time to have meaningful conversations for the development of strategic relationships. This is not possible with a multitude of exhibitors. This conference currently has a 90% return rate of exhibitors from last year.

Other conference highlights include a performance by the Washington D.C. political satire comedy troupe, “Capitol Steps” and the launching of the Immuno Laboratories “Advantage IgE” program that enables primary care physicians to diagnose and treat allergies in their office-with no referrals necessary.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Immuno Laboratories, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Immuno Laboratories 2008 Practice Development Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Constance Armstrong - ImmunoLabs.com 
954-691-2500 constancea[.]immunolabs.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Immuno Laboratories, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Immuno Laboratories, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)